Clinical trial
Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
NCT00194064 · University Hospitals Cleveland Medical Center, Other · Terminated
Key facts
| NCT number | NCT00194064 |
|---|---|
| Title | Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine |
| Official title | Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Olanzapine |
| Enrollment | 18 |
| Start date | Jul 1, 2002 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: